David James Farabee



David James FarabeeCurriculum VitaePERSONAL HISTORYOffice Address: NYU Department of Population Health 180 Madison Avenue,New York, NY Phone:310.963.0009E-mail:david.farabee@EDUCATION1985University of Texas, AustinB.A., Psychology1988Texas A&M University, CommerceM.S., Psychology1992Texas Christian UniversityPh.D., Experimental PsychologyPROFESSIONAL EXPERIENCE2018Professory Emeritus UCLA; Research Professor NYU2016-2018Professor-in-Residence. UCLA Department of Psychiatry & Biobehavioral Sciences. Co-Director, ISAP. 2008-presentProfessor-in-Residence. UCLA Department of Psychiatry & Biobehavioral Sciences. 2005-2008Research Psychologist at the University of California at Los Angeles Integrated Substance Abuse Programs (ISAP). 2000-2004Associate Research Psychologist at the University of California at Los Angeles Integrated Substance Abuse Programs (ISAP). 1997-1999Assistant Research Psychologist at the University of California at Los Angeles Integrated Substance Abuse Programs (ISAP). 1995-1997Assistant Professor of Psychiatry and Research Scientist at the Center on Drug and Alcohol Research at the University of Kentucky. 1993-1995Lead Analyst, Texas Commission on Alcohol and Drug Abuse. 1989-1992Research Assistant, Institute of Behavioral Research, Texas Christian University. PROFESSIONAL ACTIVITIES Community ActivitiesSenior Fellow, UC Criminal Justice & Health Consortium Advisor to the Africa Mental Health Foundation (AMHF) in the area of?alcohol and substance abuse ().Member of the County of Los Angeles Department of Mental Health Adult Systems of Care—Jail Mental Services, Quality, Academics and Research Advisory Board.Member of the U.S. Health and Human Services Advisory Committee on HIV and STD Prevention of the Centers for Disease Control (2002-2005).Co-Editor of the Offender Programs Report (New York: Civic Research Institute) Visiting professor at the Universidad Autonoma de Nuevo Leon in Monterrey, Mexico (2001-present) Member of the UCLA Institutional Review Board (2006-2009)RESEARCH GRANTS RECEIVED ActiveDepot Pharmacotherapies for Opioid-Dependent Offenders: Outcomes and Costs1 U01 DA034743-01A1 (PI: Farabee)06/01/13 - 05/31/17NIH/NIDA$2,500,000The major goal of this project is to assess depot naltrexone (alone and combined with a patient navigator) relative to treatment as usual, with regard to patient acceptance, effectiveness, and economic benefits.From Behind Bars to Between the Cracks20163857 (PI: Farabee) 5/1/17 – 4/30/18 Charles Koch Foundation Parolees (N=100) with serious mental illness will be participate in brief, monthly interviews over a 12-month period to assess their access to and participation in psychiatric services, reasons why they entered/did not enter care, reasons for remaining/dropping out, perception of services, whether or not they were transferred from CDCR-funded to county-funded care, overall psychological functioning, conditions around revocations/re-arrests (if applicable), and how existing post-release services can be improved.Beta Gov R3988-01 (PI: Farabee) 8/1/16 /31/18New York University/Laura and John Arnold Foundation Dr. Farabee serves as Co-Director. He supervises development of appropriate study protocols and measures for interacting with RCT participants, and he works in collaboration with practitioners and other members of the BetaGov team regarding overall protocol development, implementation, and data analyses.Evaluation of Core 4 Success in Ventura County20171243 (PI: Farabee) 6/15/17 – 12-31/21Ventura County/Children and Family First Commission Dr. Farabee provides evaluation services for the Ventura County Core 4 Success project, an approach to expand the evidence-based services of local providers to individuals on formal pleted Research An Experimental Comparison of Telepsychiatry and Conventional Psychiatry for Mentally Ill ParoleesDOJ/NIJ 2010-DJ-BX-2002 (PI: Farabee)01/01/11 - 09/30/15 The major goal of this project was to compare the effectiveness of telepsychiatry via video conferencing relative to face-to-face sessions with regard to satisfaction with treatment/therapeutic alliance, medication adherence, session attendance, psychological functioning, and recidivism. Evaluation of the Integrated Services for Mentally Ill Parolees (ISMIP) and Case Management Reentry Pilot (CMRP) ProgramsContract No.5600005097 (PI: Farabee)California Department of Corrections and Rehabilitation 01/01/15-12/31/16 2016This project involves a process and outcome evaluation of the ISMIP and CMRP programs. The process evaluation is devoted to describing how these programs actually function, and to what extent eligible parolees participate in the available services. The outcome evaluation will focus on arrests, convictions, and time to first arrest for program referrals compared to matched comparison subjects drawn from concurrent release samples.Enhancing Follow-up Rates Through a Rechargeable Incentive Card (RIC) System2 R42 DA025387 (PI: Farabee)05/01/12 - 01/31/14NIH/NIDA/Calance Corporation$335,020The major goal of this Phase II Small Business Technology Transfer (STTR) project is to conduct a randomized field test of the rechargeable incentive card (RIC) system developed in Phase I, and to execute a detailed plan to commercialize the finalized set of products and services for the purpose of improving validity and generalizability of longitudinal substance abuse research and follow-up rates.An Experimental Comparison of Telepsychiatry and Conventional Psychiatry for Mentally Ill Parolees2010-90983-CA-IJ (PI: Farabee)10/01/10-06/30/15National Institute of Justice/U.S. DOJ$608,248 The major goal of this project is to evaluate the effectiveness of telepsychiatry for parolees relative to conventional face-to-face sessions. Outcomes include therapeutic alliance, medication adherence, clinic attendance, psychological functioning, and recidivism. It Came from the North: Estimating the Production of Synthetic Drugs in Quebec, Canada2010-94019-CA-IJ (PI: Farabee)01/01/11-12/31/14National Institute of Justice/U.S. DOJ $367,845The major goal of this project is to estimate the size of synthetic drug production (methamphetamine in particular) in Quebec, Canada, assess its export potential, and explore implications for counter-narcotics policies. The Pacific Coast Research Center Of the NIDA CJ-DATS5 U01 DA16211-03 (Co-PI: Farabee)09/30/02 - 09/01/13 NIH/NIDA$3,265,000The major goal of this project is to collaborate with other CJ-DATS Research Centers in developing and evaluating system-level interventions for drug abusing offenders in prison and on parole.Evaluation of the P3Benefits ProgramC08.145 (PI: Farabee) 11/1/08—10/31/11 State of California/CDCR $268,584In accordance with the California Logic Model, to insure a continuum of care, the Division of Adult Parole Operations (DAPO) is utilizing contracted benefits social workers (BSW) within the prisons to apply for federal and state benefit entitlements prior to an inmate’s return to the community. Benefits that will be applied for are: SSA benefits, State sponsored Medi-Cal, and VA benefits. In accordance to Provision 22: Reducing Recidivism, the purpose of this evaluation is to provide CDCR Executive Staff and the California State Legislature with information about the effectiveness of the P3 Benefits Program.A Randomized Controlled Trial of the Second Chance Program for Ex-Inmates2008-7752 (PI: Farabee)09/01/08 - 09/01/11Smith Richardson Foundation$345,435The major goal of this project was to conduct a process and outcome evaluation and a cost analysis of the Second Chance’s PREP program.Four Models of Telephone Support for Stimulant Recovery1 R01 DA18208 (PI: Farabee)04/01/05 - 03/31/11 NIH/NIDA$2,627,680The major goal of this project wais to compare the efficacy of four low-cost, telephone support protocols for patients who have completed the intensive phase of a structured, outpatient stimulant abuse treatment program.Enhancing Follow-up Rates Through a Rechargeable Incentive Card (RIC)1 R41 DA025387-01 (Farabee)07/01/08 - 3/31/11Calance Corp/NIH/NIDA$35,097SystemThe major goal of this project was to develop a national network that supports a rechargeable incentive card (RIC) system designed to enhance follow-up rates and to assess the feasibility and commercial potential of the system.The Utility of the COMPAS in Assessing Needs and Predicting Recidivism C06.417 (PI: Farabee)01/01/07 – 12/31/09State of California/CDC$300,000The purpose of this project was to assess the predictive validity of a risk assessment tool (COMPAS) recently adopted by the California Department of Corrections. Our study evaluated the extent to which this instrument can correctly classify offenders who pose the greatest risks upon release. Treatment System Impact & Outcomes of Proposition 36 in 5 California Counties5 R01 DA15431-03 (PI: Hser; Co-PI: Farabee)07/20/02 - 06/30/06 NIH/NIDA$3,397,381The major goal of this project was to examine the treatment system impact and outcomes of Proposition 36 in five selected counties and to explore the effects of the implementation of Proposition 36 on California’s treatment delivery system, the system’s response, and the relationships between the treatment system and the criminal justice system.Evaluation of the Mental Health Services Continuum Program (MHSCP)P02.0016 (PI: Farabee)7/02 - 6/08State of California/CDC$750,000The major goal of this project was to evaluate the Mental Health Services Continuum Program (MHSCP) with respect to how well the in-prison and community-based components were planned, developed, and implemented, and to what extent do activities and services achieved the program’s goals and objectives.CDC Prison Treatment Expansion Project: Program Evaluations and Research StudiesContract No. 98.346 (PI: Prendergast; Co-PI: Farabee)7/99-6/04 California Department of Corrections$3,750,552The purpose of this project was to conduct process and outcome evaluations of six prison-based therapeutic community treatment programs funded by the California Department of Corrections. The project also included examination of special topics related to prison-based treatment programs that are of interest to the Department.Substance Abuse, Medication Adherence, and Criminality among Mentally Ill Parolees99-CE-VX-0003 (PI: Farabee)1/00-6/02 National Institute of Justice$300,000 This study was designed to accomplish five primary goals: (1) assess the rates of antipsychotic medication adherence among severely mentally ill parolees, (2) validate the use of hair assays as a means for assessing medication compliance, (3) compare medication adherence of mentally ill (non-substance dependent) and comorbid parolees, (4) identify reasons for adherence/non-adherence (according to clinical staff and parolees), and (5) measure the extent to which medication adherence is associated with various parolee outcomes such as violent behavior, return to custody, and psychosocial functioning. Evaluation of the California Youth Authority Residential Substance Abuse Programs Contract No. 822-103 (PI: Farabee)7/98-8/01 California Youth Authority$426,256The purpose of the evaluation was to determine the extent to which program components are being implemented and to identify factors that either impede or enhance the delivery of program services. Funded by the Office of Criminal Justice Planning, the CYA-RSAT programs are currently operating at nine institutional sites across the state. LECTURES & PRESENTATIONS 1992Lehman, W.E.K., Farabee, D., Holcom, M.L., & Simpson, D.D. Prediction of substance use: Unique contributions of personal and job environment factors. Paper presented at the meeting of the Society for Industrial Organizational Psychologists, Montreal, Canada.1994Crouch, B., Dyer, J., Farabee, D., Gorton, J., & Bodiford, C. Field problems in collecting self-report, urine and hair data on offenders' substance use. Paper presented at the meeting of the American Society of Criminology, Miami, FL.1995Wallisch, L. and Farabee, D. Gambling and problem gambling among women inTexas prisons. Paper presented at the meeting of the Ninth National Conference on Gambling Behavior, San Juan, Puerto Rico.1995Farabee, D., McClellan, D., & Crouch, B. Early victimization, drug use, and criminality: A comparison of male and female prisoners. Poster session presented at the meeting of the Academy of Criminal Justice Sciences, Boston, MA.1996Leukefeld, C.G. and Farabee, D. Mandatory treatment, HIV, and injecting drug users. Invited paper presented at the Spanish Interdisciplinary AIDS Society’s Third National Meeting on AIDS, Galicia, Spain.1996Farabee, D. and Leukefeld, C.G. Injection drug use and HIV seropositivity among incarcerated men and women in the United States. Invited paper presented at the Spanish Interdisciplinary AIDS Society’s Third National Meeting on AIDS, Galicia, Spain.1996Farabee, D., Leukefeld, C.G., Logan, T., Beaven, S., McKiernan, P., Woolley, S., Cavanaugh, B., Clayton, R., Parker, J., Peyton, B., Cantrill, J., Huffman, M., & McCoy, C. Substance abuse treatment availability by AIDS-risk severity. Paper presented at the 104th Annual Convention of the American Psychological Association, Toronto, Canada.1996Farabee, D., Leukefeld, C.G., & Logan, T.K. City size, city seroprevalence, and HIV risk behaviors among out-of-treatment drug users. Paper presented at the National Institute on Drug Abuse Symposium: Perspectives on Rural Substance Abuse, Ames, IA.1996Farabee, D., & McClellan, D.S. Perceptions of punishment: A comparison of male and female prisoners. Paper presented at the annual meeting of the Academy of Criminal Justice Sciences, Las Vegas, Nevada.1997Farabee, D. Criminal justice treatment: The U.S. experience. Invited paperpresented at the Royal Society of Medicine’s conference “Drug Misusers: Whose Business is it?” London, England. 1997 Farabee, D., & Leukefeld, C.G. HIV risk among high-frequency arrestees. Paper presented at the Annual Meeting of the American Society of Criminology, November 17th, San Diego, California.1997Farabee, D., & Leukefeld, C.G. Self-assessed HIV risk and the efficacy of HIV prevention among street drug users. Poster presented at the 125th Annual Meeting of the American Public Health Association, Indianopolis, Indiana.1997Farabee, D., & Leukefeld, C.G. Missed opportunities for AIDS prevention: Criminal justice and substance abuse treatment settings in a rural state. Paper presented at the 105th Annual Convention of the American Psychological Association, Chicago, IL.1997Leukefeld, C.G., Farabee, D., Cottler, L., Desmond, D., Hoffman, J., Inciardi, J., & Wechsberg, W. A multisite study of real and perceived HIV risk by county population density. Paper presented at the 59th Annual Scientific Meeting of the College on Problems of Drug Dependence, Nashville, TN.1997Hays, L., Farabee, D., & Miller, W. Caffeine and nicotine use in an addicted population. Poster presented at the Conference of the American Society of Addiction Medicine, San Diego, CA. 1998Anglin, M.D., & Farabee, D. The role of coercion in offender drug treatment. Invited paper presented to the Physician Leadership on National Drug Policy, November 10, Washington, DC.1998 Farabee, D., Prendergast, M.L., Cartier, J., & Anglin, M.D. Proximal outcomes from California’s largest in-prison therapeutic community. Paper presented at the Annual Meeting of the American Society of Criminology, November 12th, Washington, DC.1998Anglin, D.A. & Farabee, D. Coerced treatment of criminal offenders. Paper presented at the Annual Conference of the American Society of Addiction Medicine, New Orleans, LA.2000Farabee, D. , Prendergast, M.L., & Cartier, J. Psychosocial changes among special populations in a prison-based therapeutic community. Paper presented at the Annual Meeting of the American Society of Criminology, November 15th, San Francisco, CA.2000Farabee, D., Shen, H., Hser, Y.I., Grella, C., & Anglin, M.D. The effect of substance abuse treatment on adolescent criminality. Paper presented at the meeting of the Academy of Criminal Justice Sciences, New Orleans, LA. 2001Farabee, D., & Sanchez, S. Substance abuse and medication adherence among mentally ill parolees. Poster presentation at the Annual Meeting of the American Psychological Association, August 24-28, 2001, San Fransico, CA. 2001Farabee, D., & Sanchez, S. Measuring drug use and medication adherence among mentally ill parolees. Presented at the Annual Meeting of the American Society of Criminology, November 7-10, 2001, Atlanta, GA. 2001 Farabee, D., Prendergast, M.L., & Cartier, J. Methamphetamine use and HIV risk among substance-abusing offenders in california. Poster presented at the 63rd Annual Scientific Meeting of the College on Problems of Drug Dependence, Scottsdale, AZ.2002Messina, N., Farabee, D., & Rawson, R. Treatment responsivity of cocaine-dependent patients with antisocial personality disorder. American Psychological Association, August 25, Chicago, Illinois. 2004Farabee, D. The effectiveness of needle exchange programs. Invited paper presented at the Third Meeting of the World Health Organization’s Eastern Mediterranean Regional Advisory Panel, Cairo, Egypt.2004Farabee, D., Hser, Y.I., Anglin, M.D., & Huang, D. Recidivism among an early cohort of California’s Proposition 36 offenders. Presented at the Annual Meeting of the American Society of Criminology, November 17, 2004, Nashville, TN.2005 Farabee, D., & Garner, B. Psychometrics of the Inmate Pre-Release Assessment (IPASS). Presented at the Annual Meeting of the American Society of Criminology, November 18, 2004, Toronto, Canada. 2006 Farabee, D. Is Treatment really the road to rehabilitation? Promoting offender change through accountability. Invited paper presented at the Semi-Annual Meeting of the National Research Council’s Committee on Law and Justice. Irvine, CA. 2007Farabee, D. Evidence-based practices for offenders. Invited paperpresented at the annual meeting of the Oregon District Attorneys’ Association. Bend, OR. 2007Farabee, D. The Inmate Pre-Release Assessment (IPASS). Presented at the Annual Meeting of the College on Problems of Drug Dependence, June 20, 2007, Quebec City, Canada.2007 D. Farabee, R. Rawson, M. Karno, V. Pearce, J. Brummer, S. Cousins, & S. Patel. Four models of telephone support for stimulant recovery. American Academy of Addiction Psychiatry, San Diego, California, 2007. 2008Farabee, D. Effective interventions for addicted offenders. Invited presentation at the Holyrood Magazine conference, “Beyond McLeish: New Ideas, Lasting Solutions—Seeking Change in Scotland’s Sentencing Policy.” September 8, 2008. Edinburgh, Scotland. 2008 D. Farabee, R. Rawson, M. Karno, V. Pearce, A. Bellows, J. Hemberg, S. Cousins, & S. Patel. Continuing care for stimulant recovery: An experimental test of telephone support. Presented at the Annual Meeting of the College on Problems of Drug Dependence, June 19, 2008. San Juan, Puerto Rico.2009D. Farabee. HIV and Corrections: An International Perspective. Invited presentation at the International Conference on Global Health. December 8, 2009. Taipei, Taiwan. 2009D. Farabee & S. Zhang. Managing an on-the spot lottery in reentry services. Presented at the Annual Meeting of the American Society of Criminology, November 18, 2009, Philadelphia, PA. 2010D. Farabee, Wright, B., & Zhang, S. What is the evidence for evidence-based offender programs? Presented at the Stockholm Criminology Symposium, June 15, 2010. Stockholm, Sweden.2010D. Farabee & S. Zhang. A critical examination of offender needs assessment: Are all those questions really necessary? Presented at the Annual Meeting of the American Society of Criminology, November 17, 2010, San Francisco, CA. 2011D. Farabee, S. Zhang, & B. Wright. Impact of a reentry program on employment and recidivism: Results of a randomized field experiment. Presented at the Annual Meeting of the American Society of Criminology, November 18, 2011, Washington, D.C. 2012 D. Farabee & Zhang, S. Effect-size inflation of post-hoc versus intent-to treat analyses of experimental offender interventions. Presented at the Stockholm Criminology Symposium, June 13, 2012. Stockholm, Sweden.2013D. Farabee. Global epidemiology of amphetamine-type stimulants. Invited presentation at the International Conference on Addiction. March 6, 2013. Jazan, Saudi Arabia.2013D. Farabee, S. Calhoun, & R. Veliz. An experimental comparison of telepsychiatry and conventional psychiatry for mentally ill parolees. Presented at the Annual Meeting of the American Society of Criminology, November 20, 2013, Atlanta, GA. 2014D. Farabee, S. Zhang, & S. Calhoun. Clinical value and cost savings associated with using telepsychiatry in prisons: Results of a psychiatrist survey. Presented at the Annual Meeting of the American Society of Criminology, November 18, 2011, San Francisco, CA. BIBLIOGRAPHYResearch Papers—Peer Reviewed 1993Farabee, D., Holcom, M.L., Ramsey, S., & Cole, S. Social anxiety and speaker gaze in a persuasive atmosphere. Journal of Research in Personality, 27, 365-376.1993Farabee, D., Nelson, R., Spence, R. Psychosocial profiles of criminal justice- and non-criminal justice-referred clients in treatment. Criminal Justice and Behavior, 20, 336-346.1995Farabee, D., Simpson, D.D., Dansereau, D., & Knight, K. Cognitive inductions into treatment among drug users on probation. Journal of Drug Issues, 25, 669-682.1995Farabee, D., Wallisch, L.S., & Maxwell, J.C. Substance use among Texas Hispanics and non-Hispanics: Who's using, who's not, and why. Hispanic Journal of Behavioral Sciences, 17, 523-536.1995Lehman, W.E.K, Farabee, D., Holcom, M.L., & Simpson, D.D. Prediction of substance use in the workplace: Unique contributions of demographic and work environment variables. Journal of Drug Issues, 25, 253-274.1996Farabee, D., & Fredlund, E.V. Self-reported drug use among recently admitted jail inmates: Estimating prevalence and treatment needs. Substance Use and Misuse, 31, 423-435.1997Leukefeld, C.G, Gallego, M.A., & Farabee, D. Drugs, crime, and HIV. Substance Use and Misuse, 32(6), 749-756.1997Maxwell, J.C., Wallisch, L.S., Farabee D., & Spence, R.T. A model for assessing prevention needs. Journal of Primary Prevention, 17(3),315-334 .1997McClellan, D., Farabee, D., & Crouch, B. Early victimization, drug use, and criminality: A comparison of male and female prisoners. Criminal Justice and Behavior, 24(4), 455-476.1998Logan, T.K., Leukefeld, C.G., & Farabee, D. Sexual and drug use behaviors among women crack users: Implications for prevention. AIDS Education and Prevention, 10 (4) 327-340.Farabee, D., Leukefeld, C.G., & Hays, L.R. Accessing drug abuse treatment: Perceptions of out-of-treatment injectors. Journal of Drug Issues, 28(2), 381-394. 1998Farabee, D., Prendergast, M.L., & Anglin, M.D. The effectiveness of coerced treatment for drug-abusing offenders. Federal Probation, 62, 3-10.1998Hays, L.R., Farabee, D., & Miller, W. Caffeine and nicotine use in an addicted population. Journal of Addictive Diseases, 17(1), 47-54.1998Leukefeld, C.G., Logan, T., Martin, S. Purvis, R.T., & Farabee, D. Health service utilization among drug -abusing offenders. American Behavioral Scientist, 41(8), 1122-1135.1999Farabee, D., Prendergast, M.L., Cartier, J., Wexler, W., Knight., K., & Anglin, M.D. Barriers to implementing effective correctional treatment programs. The Prison Journal, 79(2), 150-162.Farabee, D., & Leukefeld, C.G. Opportunities for AIDS prevention in a rural state in criminal justice and substance abuse treatment settings.Substance Use and Misuse, 34 (4&5), 617-632.1999Hays, L.R., Farabee, D., & Patel, P. Characteristics of cocaine users in a private inpatient setting. Journal of Drug Education, 29 (2), 157-164.1999Leukefeld, C.G., Logan, T.K., Farabee, D., Watson, D., Spalding, H., & Purvis, R. Drug dependency and HIV testing among state prisoners. Population Research and Policy Review, 18, 55-69.2001Farabee, D., Joshi, V., & Anglin, M.D. Addiction careers and criminal specialization. Crime & Delinquency, 47(2), 196-220. 2001Farabee, D., Shen, H., Hser, Y.I., Grella, C., & Anglin, M.D. The effect of substance abuse treatment on adolescent criminality. Journal of Adolescent Research, 16(6), 679-696.2001Hegamin, A.H., Anglin, G., & Farabee, D. Gender differences in the perception of drug treatment: Assessing drug treatment for youthful offenders. Substance Use and Misuse, 36, 2159-2170.2001Prendergast, M.L., Farabee, D., & Cartier, J. The impact of in-prison therapeutic community programs on prison management. Journal of Offender Rehabilitation, 32(3), 63-78.2002Burdon, W.M., Farabee, D., Prendergast, M.L., Messina, N.P., & Cartier, J. Prison-based therapeutic community programs: Implementation and operational issues. Federal Probation, 66(3), 3-8. 2002Farabee, D. Editor of special issue: Making people change: The effectiveness of coerced psychological treatment. Criminal Justice and Behavior, 29(1). 2002Farabee, D. Re-examining Martinson’s critique: A cautionary note for evaluators. Crime & Delinquency, 48(1), 189-192. 2002Farabee, D., Prendergast, M.L., & Cartier, J. Methamphetamine use and HIV risk among substance-abusing offenders in California. Journal of Psychoactive Drugs, 34(3), 295-300. (PMID: 12422940) 2002Farabee, D., Rawson, R.A., & McCann, M. Adoption of drug avoidance activities among patients in contingency management and cognitive-behavioral treatments. Journal of Substance Abuse Treatment, 23, 343-350. (PMID: 12495796)2002Farabee, D., Shen, H., & Sanchez, S. Perceived coercion and treatment need among mentally ill parolees. Criminal Justice and Behavior, 29(1), 76-86. 2002Leukefeld CG, Logan TK, Farabee D, Clayton R., Drug use and AIDS: estimating injection prevalence in a rural state. Subst Use Misuse. 2002, 37(5-7), 767-782. (PMID: 12117069)2002 Leukefeld, C.G., Farabee, D., McDermeit, M., Dennis, M.L., Wechsberg, W.M., Inciardi, J.A., Surratt, H.L., Compton, W.M., Cottler, L.B., Klein, H., Hoffman, J.A., Desmond, D., & Logan, T.K. Real and perceived HIV risk by population density. Journal of Drug Issues, 31(4), 889-900.2002Prendergast, M.L., Farabee, D., Cartier, J., & Henken, S. Coerced treatment within a prison setting: Impact on psychosocial change during treatment. Criminal Justice & Behavior, 29 (1), 5-26.2002Rawson, R.A, Huber, A., McCann, M., Shoptaw, S., Farabee, D., Reiber, C., & Ling, W. A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence. Archives of General Psychiatry, 59, 817-824. (PMID: 12215081)2003Hegamin, A., & Farabee, D. RSAT programs for youngh offenders in California: A Descriptive Study. Journal of Offender Rehabilitation, 37, 123-138.2003Hser, Y.I., Teruya, C., Evans, E., Longshore, D., Grella, C., & Farabee, D. Treating drug-abusing offenders: Initial findings from a five-county study on the impact of California’s Proposition 36 on treatment system and patient outcomes. Evaluation Review, 27 (5),479-505. (PMID:14531316) 2003Messina, N., Farabee, D., & Rawson, R. Treatment responsivity of cocaine-dependent patients with antisocial personality disorder in cognitive behavioral and contingency management interventions. Journal of Consulting and Clinical Psychology, 71(2), 320-329. (PMID: 12699026)2004Farabee, D., Hser, Y.H., Anglin, M.D., & Huang, D. Recidivism among an early cohort of California’s Proposition 36 offenders. Criminology & Public Policy, 3(4), 501-522. 2004Farabee, D., Shen, H., & Sanchez, S. Program-level predictors of antipsychotic medication adherence among parolees. International Journal of Offender Therapy and Comparative Criminology, 48(5), 561-571. (PMID: 15358931)2004Farabee, D., & Shen, H. Antipsychotic medication adherence, cocaine use, and recidivism among a parolee sample.Behavioral Sciences and the Law, 22, 467-476. (PMID: 15282835)2004Prendergast, M.L., Campos, M., Farabee, D., Evans, W., & Martinez, J. Reducing substance use in prison: The California Department of Corrections Drug Reduction Strategy Project. The Prison Journal, 84 (2), 265-280. 2006Cartier, J., Farabee, D., & Prendergast, M.L. Methamphetamine use, violence, and recidivism among California parolees. Journal of Interpersonal Violence, 21, 435-445. (PMID: 16501213)2007 Farabee, D., Knight, K., Garner, B., & Calhoun, S. The Inmate Pre-Release Assessment (IPASS) for re-entry planning. Criminal Justice & Behavior, 34(9), 1188-1197.2007Burdon, W.M., Dang, J., Prendergast, M. L., Messina, N.P., & Farabee, D. Differential effectiveness of residential versus outpatient aftercare for parolees from prison-based therapeutic community treatment programs. Substance Abuse Treatment, Prevention, and Policy, 2:16. (PMID: 17504540) (PMCID: PMC1884138)2007 Grella, C.E., Greenwell, L., Prendergast, M.L., Farabee, D., Hall, E., Cartier, J., & Burdon, W. Organizational characteristics of drug abuse treatment programs for offenders. Journal of Substance Abuse Treatment, 32, 291-300. (PMID: 17383553) (PMCID: PMC1941644)2009Prendergast, M., Greenwell, L., Farabee, D., & Hser, Y.I. Influence of perceived coercion and motivation on treatment completion and re-arrest among substance-abusing offenders. J Behav Health Serv Res., 36(2), 159-76. (PMID: 18516684) 2010 Peng, E.Y., Lee, M., Morisky, D.E., Yeh, C.Y., Farabee, D., Lan, Y.C., Chen, Y.M.A., Lyu, S.Y. Psychiatric morbidity in HIV-infected male prisoners. Journal of the Formosan Medical Association, 109 (3), 177-184. 2010Peng E.Y., Yeh C.Y., Lyu S.Y., Morisky D.E., Chen Y.M., Lee M.B., Farabee D., & Malow R. Prevalence and correlates of lifetime suicidal ideation among HIV-infected male inmates in Taiwan. AIDS Care, 10, 1212-1220. PMID: 20845113 2011Farabee, D., Hawken, A., & Griffith, P. Tracking and incentivizing substance abusers in longitudinal research: Results of a survey of NIDA-funded investigators. Journal of Addiction Medicine, 5(2), 87-91. [PMC3140135]2011Farabee, D., Zhang, S.X., & Yang, J. A preliminary examination of offender needs assessment: Are all those questions really necessary? Journal of Psychoactive Drugs, 43, 1-7. 2012Farabee, D. Zhang, S.X., & Wright, B. Managing an on-the-spot lottery in re-entry services. Journal of Experimental Criminology, 8,241–253. 2012Karno, M., Farabee, D., Brecht, M.L., & Rawson, R.A. Patient reactance moderates the effect of directive telephone counseling for methamphetamine users. Journal of Studies on Alcohol and Drugs, 73, 844–850.2012 Ling, W., Farabee, D., Liepa, D., & Wu, L. T. The Treatment Effectiveness Assessment (TEA): an efficient, patient-centered instrument for evaluating progress in recovery from addiction. Substance Abuse, 3, 129-136.2012Wright, B., Zhang, S.X., & Farabee, D. A squandered opportunity: A review of SAMHSA’s National Registry of Evidence-based Programs and Practices (NREPP) for offenders. Crime & Delinquency, 6, 954 – 972.2013Farabee, D, Cousins, S.J., Brecht, M.L., Antonini, V.P., Lee, A.B., Brummer, J., Hemberg, J., Karno, M., & Rawson, R.A. A Comparison of four telephone-based counseling styles for recovering stimulant users. Psychology of Addictive Behavior, 27.1, 223. (PMCID: PMC3500433, NIHMSID: NIHMS396172) 2013Farabee, D., McCann, M., Brecht, M.L., Cousins, S.J., Antonini, V.P., Lee, A.B., Brummer, J., Hemberg, J., Karno, M. & Rawson, R.A. An analysis of relapse prevention factors and their ability to predict sustained abstinence following treatment completion. American Journal of Addictions, 22(3), 206-211. 2014Farabee, D., Zhang, S.X., & Wright, B. An experimental evaluation of a nationally recognized employment-focused offender reentry program. Journal of Experimental Criminology, 1-14.2014Lyu, S.Y., Chi.,Y.C., Farabee,. D., Tsai, L.T., Lee, M.B., Lo, F.E., & Morisky, D.E. Psychological distress in an incarcerated juvenile population. Journal of the Formosan Medical Association.2014Wright, B., Zhang, S.X., & Farabee, D. Prisoner reentry research from 2000-2010: Results of a narrative review. Criminal Justice Review, 39(1), 37-57.2014Zhang, S.X., Roberts, R., and Farabee, D. An analysis of prisoner reentry and parole risk using COMPAS and traditional criminal history measures. Crime & Delinquency, 60(2), 167-192.2015Nyamathi, A. M., Reback, C. J., Shoptaw, S., Salem, B. E., Zhang, S., Farabee, D., & Khalilifard, F. Impact of community-based programs on incarceration outcomes among gay and bisexual stimulant-using homeless adults. Community Mental Health Journal, 1-6. 2015Nyamathi, A. M., Zhang, S., Salem, B. E., Farabee, D., Hall, B., Marlow, E., & Yadav, K. (2015). A randomized clinical trial of tailored interventions for health promotion and recidivism reduction among homeless parolees: outcomes and cost analysis. Journal of Experimental Criminology, 1-26. 2016Ahalt, C., Haney, C., Rios, S., Fox, M.P., Farabee, D., and Williams, B., 2017. Reducing the use and impact of solitary confinement in corrections. International Journal of Prisoner Health, 13(1), 41-48.2016Farabee, D., Hawken, A., Calhoun, C., Veliz, R., Grossman, J., & Zhang, Y. Tracking and locating itinerant subjects with a rechargeable incentive card: Results of a randomized trial. Substance Use & Misuse, 51(5), 658-663.2016Farabee, D., Shulte, M., Gonzales, R., & Grella, C.E. Technological aids for improving longitudinal research on substance use disorders. BMC Health Services Research, 16(1), 1.2016Morselli, C., Zhang, S.X., Bouchard, M., Coullet, M, & Farabee, D. It came from the north: Assessing the claim of Canada's rising role as a global supplier of synthetic drugs. Crime, Law & Social Change, 1-24.2016Farabee, D., Calhoun, S., & Veliz, R. An experimental comparison of telepsychiatry and onsite psychiatry for parolees. Psychiatric Services, 67(5), 562-565. 2016Farabee, D., Hillhouse, M., Condon, T., McCrady, McCollister, & Ling, W. Injectable pharmacotherapy for opioid use disorders (IPOD). Contemporary Clinical Trials, 49, 70-77. 2017 Nyamathi, A., Salem, B. E., Farabee, D., Hall, E., Zhang, S., Faucette, M., & Yadav, K. (2017). Impact of an intervention for recently released homeless offenders on self-reported re-arrest at 6 and 12 months. Journal of Addictive Diseases, 36(1), 60-71.2018Farabee, D. Current and promising pharmacotherapies for substance use disorders among justice-involved population. European Journal on Criminal Policy and Research, 1-9.Research Papers—Non-Peer Reviewed1998Lehman, W.E.K., Farabee, D, & Bennett, J.B. Perceptions and correlates of coworker substance abuse. Employee Assistance Quarterly, 13(4), 1-22.2006Farabee, D. An evaluation of California’s Mental Health Services Continumm Program for parolees. Corrections Today, 68(7), 38-41.2015Farabee, D. Book Review: The methamphetamine industry in America: Transnational cartels and local entrepreneurs. Criminal Justice Review, 0734016815573305. Chapters2001Farabee, D. and Leukefeld, C.G. Recovery and the criminal justice system. In J.J. Platt, F.M. Tims, and C.G. Leukefeld (Eds.) Relapse and Recovery Processes in the Addictions, pp. 40-59. New Haven, CT: Yale University2002Farabee, D. & Leukefeld, C.G. HIV/AIDS in the criminal justice system. In C.G. Leukefeld, F. Tims, and D. Farabee (Eds.) Treatment of Drug Offenders: Policies and Issues, pp. 172-185. New York: Springer.2004 Farabee. D., Shen, H., Prendergast, M.L, & Cartier, J. The effectiveness of coerced admission into prison-based drug treatment. In K. Knight and D. Farabee (Eds.), Treating Addicted Offenders: A Continuum of Opportunities, pp. 31:1-12. New York: Civic Research Institute. 2004Longshore, D., Prendergast, M., & Farabee, D. Coerced treatment for drug-using criminal offenders. In P. Bean (Ed.), Drug Treatment: What Works?, pp. 110-122. London: Taylor & Francis Books.2005Satel, S., & Farabee, D. The role of coercion in drug treatment. In J.H. Lowinson, P. Ruiz, R.B. Millman, & J.G. Langrod (Eds.) Substance Abuse: A Comprehensive Textbook, pp. 690-707. New York: Lippincott Williams & Wilkins.2006 Messina, N., Farabee, D., & Rawson, R. Cocaine-dependent patients with antisocial personality disorder (Chapter 5). In F. Columbus (Ed.) Cocaine Abuse: New Research. Hauppauge, NY: Nova Science Publishers, Inc. 2007Farabee, D. Monitoring drug use and medication adherence among mentally ill parolees. In K. Knight and D. Farabee (Eds.), Treating Addicted Offenders: A Continuum of Opportunities, Vol. II, pp. 20:1-3. New York: Civic Research Institute.2009Farabee, D., & Hawken, A. Methamphetamine and crime. In J. M. Roll, R. Rawson, W. Ling, & S. Shoptaw (Eds.). Methamphetamine Addiction. pp. 157-151. New York: Guilford.2015Farabee, D., Rawson, R.A., & Gawad, T. Treatment in the criminal justice system. In Nady El-Guebaly, Marc Galanter and Giuseppe Carrá (Eds), Textbook of Addiction Treatment: International Perspectives. Heidelberg, Germany: Springer. Editorials2002Farabee, D. Addicted to treatment: Ideology is trumping science in our quest to rehabilitate offenders. Forbes, December 23. p.60.2002Farabee, D., Prendergast, M.L., & Cartier, J. Alcohol, the “un-drug.” Psychiatric Services, 53 (11), 1375-1376. (PMID: 12407261)2006Farabee, D. Why the expansion of offender programs is premature. Journal of Community Corrections, 16(1), 9-10.2006Farabee, D. Reinventing criminal justice. Washington Post, February 11, . p A19.2006Farabee, D. Naltrexone as negative reinforcement: Comments on "A behavioral analysis of coercion in substance abuse treatment." Journal of Substance Abuse Treatment, 31(2), 141-142. (PMID: 17504540) 2007Farabee, D. For the Second Chance Act of 2007, great strides will come in small steps. Federal Sentencing Reporter, 20 (2), 136-137. In pressBath, E., Tolou-Shams, M. & Farabee, D. Mobile health (mHealth): Building the case for adapting emerging technologies for justice-involved youth. Journal of the American Academy of Child and Adolescent Psychiatry. Books2002Leukefeld, C.G., Tims, D., & Farabee, D. (Eds.) Treatment of Drug Offenders: Policies and Issues.New York: Springer. 2004Knight, K. & Farabee, D. (Eds.), Treating Addicted Offenders: A Continuum of Opportunities. New York: Civic Research Institute. 2005Farabee, D. Rethinking Rehabilitation: Why Can’t We Reform Our Criminals? Washington, DC: AEI Press. 2007Knight, K. & Farabee, D. (Eds.), Treating Addicted Offenders: A Continuum of Opportunities, Vol II. New York: Civic Research Institute. ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download